Jennifer Zachary insider trades

Open-market stock purchases and sales by Jennifer Zachary, EVP, General Counsel at Merck & Co, Inc, from SEC Form 4 filings since May 4, 2018.

Recent trades

DateStockTradeValue
Aug 12, 2026MRK Merck & Co, IncSold$10.7M
Aug 12, 2026MRK Merck & Co, IncBought (not open market)—
Aug 12, 2026MRK Merck & Co, IncBought (not open market)—
May 29, 2026RGNX REGENXBIO IncBought (not open market)—
May 29, 2026RGNX REGENXBIO IncBought (not open market)—
May 5, 2026MRK Merck & Co, IncBought (not open market)—
May 5, 2026MRK Merck & Co, IncBought (not open market)—
Apr 29, 2026MRK Merck & Co, IncSold (not open market)$160K
Apr 29, 2026MRK Merck & Co, IncBought (not open market)—
Feb 9, 2026MRK Merck & Co, IncSold$3.1M
Feb 9, 2026MRK Merck & Co, IncSold$6.8M
Feb 9, 2026MRK Merck & Co, IncSold$4.6M
Feb 9, 2026MRK Merck & Co, IncBought (not open market)—
Feb 9, 2026MRK Merck & Co, IncBought (not open market)—
Feb 9, 2026MRK Merck & Co, IncBought (not open market)—
Jan 26, 2026MRK Merck & Co, IncBought (not open market)$1.2M

Companies traded

  • MRK Merck & Co, Inc: 9 sales, last Aug 12, 2026
  • RGNX REGENXBIO Inc: other filings, last May 29, 2026

Get free alerts when Jennifer Zachary files a new trade →